Translational Research
Volume 155, Issue 1 , Pages 27-34, January 2010

Phosphorylation of contractile proteins in response to α- and β-adrenergic stimulation in neonatal cardiomyocytes

Feinberg Cardiovascular Research Institute, Northwestern University Medical Center, Chicago, Ill

Received 28 May 2009; received in revised form 17 September 2009; accepted 19 September 2009. published online 16 October 2009.

α- and β-Adrenergic receptor agonists induce an inotropic response in the adult heart by promoting the phosphorylation of several regulatory proteins, including myosin-binding protein C (MyBP-C), cardiac troponin I (cTnI), and phospholamban (PLB). However, the adrenergic-induced phosphorylation of these proteins has not been characterized in the developing heart. Accordingly, we evaluated MyBP-C, cTnI, and PLB phosphorylation in cultured neonatal rat cardiomyocytes (NRCMs) after α- and β-receptor activation with phenylephrine and isoproterenol. α-Receptor stimulation increased, whereas β-receptor activation reduced MyBP-C phosphorylation. Isoelectric-focusing experiments indicated that the amount of monophosphorylated MyBP-C was sensitive to α-adrenergic activation, but diphosphorylated and triphosphorylated MyBP-C levels were largely unaffected. The phosphorylation of cTnI and PLB was consistent with the mechanism observed in adult hearts: α- and β-Receptor stimulation phosphorylated both proteins. For cTnI, the greatest difference associated with β-receptor activation was observed in the diphosphorylated state, whereas α-receptor activation was associated with a marked increase in the tetraphosphorylated protein and absence of the unphosphorylated state. Despite these apparent changes in cTnI and PLB phosphorylation, β-receptor activation failed to alter calcium transients in NRCMs. Collectively, these findings suggest that, unlike cTnI and PLB, MyBP-C and inotropy are not coupled to β-adrenergic stimulation in NRCMs. Therefore, cTnI and PLB probably play a more central role in modulating contractile function in NRCMs in response to catecholamines than does MyBP-C, and MyBP-C may have a structural role in stabilizing thick filament assembly rather than influencing cross-bridge formation in developing hearts.

Abbreviations: cAMP, cyclic AMP, cTnI, cardiac troponin I, DMEM, Dulbecco's modified eagle medium, F, fluorescence, iso, isoproterenol, MyBP-C, myosin binding protein-C, MyBP-C–P1, monophosphorylated MyBP-C, RCM, neonatal rat cardiomyocyte, PKA, protein kinase A, PLB, phospholamban, Ser, serine

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by grants K08 HL079387 and R01 HL087149 from the National Institutes of Health.

PII: S1931-5244(09)00294-1

doi:10.1016/j.trsl.2009.09.007

Translational Research
Volume 155, Issue 1 , Pages 27-34, January 2010